Browsing Tag
Glenmark Pharmaceuticals
42 posts
Glenmark Pharmaceuticals gets FDA second tentative approval for Saxagliptin Tablets
Glenmark Pharmaceuticals Inc., USA has secured a second tentative approval from the United States Food and Drug Administration…
Eris Lifesciences acquires nine Glenmark Pharmaceuticals dermatology brands in INR340.48 crore deal
Eris Lifesciences’ ₹340.48 crore purchase of nine Glenmark Pharmaceuticals dermatology brands reshapes India’s pharma market. See how it impacts strategy and growth.
Glenmark Pharmaceuticals rolls out heart failure treatment Sacu V in India
Glenmark Pharmaceuticals said that it has rolled out the sacubitril + valsartan tablets for the treatment of heart…
Glenmark Pharmaceuticals launches Bumex Injection generic in US
Glenmark Pharmaceuticals said that its US-based subsidiary has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose…
Glenmark Pharmaceuticals introduces Fingolimod Capsules in US
India-based Glenmark Pharmaceuticals said that its subsidiary Glenmark Pharmaceuticals Inc., USA has introduced its Fingolimod Capsules, 0.5 mg…
Glenmark Pharmaceuticals gets FDA final approval for Buphenyl generic
Glenmark Pharmaceuticals said that it has bagged final approval for Sodium Phenylbutyrate Tablets USP, 500 mg by the…
Glenmark Pharmaceuticals launches Type 2 diabetes drug Zita D in India
Glenmark Pharmaceuticals has launched Zita D the brand name for Teneligliptin (20mg) + Dapagliflozin (5mg/10mg) fixed dose combination…
Glenmark Pharmaceuticals gets OAI communication from US FDA for Goa plant
Glenmark Pharmaceuticals Limited said that the US Food and Drug Administration (FDA) has indicated that the inspection of…
Glenmark Pharmaceuticals launches MINYM gel for acne treatment
Glenmark Pharmaceuticals has launched a topical Minocycline 4% Gel under the brand name MINYM in India for the…
Glenmark Pharmaceuticals receives FDA Form 483 with 17 observations for North Carolina facility
Glenmark Pharmaceuticals, a global pharmaceutical company based in India, announced that it has been issued Form 483 with…